Sangamo Biosciences (SGMO) has disclosed a new risk, in the Manufacturing category.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Sangamo Biosciences does not face any business risks related to mine safety disclosures, as indicated by the ‘Not applicable’ status in their risk assessment. This suggests that the company is not involved in mining operations or any activities that would require compliance with mine safety regulations. Consequently, mine safety is not a concern for Sangamo Biosciences, and it does not impact their overall risk profile. Investors and stakeholders can be reassured that this specific regulatory issue does not pose any threats to the company’s operations.
Overall, Wall Street has a Moderate Buy consensus rating on SGMO stock based on 3 Buys and 3 Holds.
To learn more about Sangamo Biosciences’ risk factors, click here.
Trending Articles:
- RTO Doesn’t Always Mean RTO: Microsoft Stock (NASDAQ:MSFT) Notches Up as Salespeople Find Exemption
- This Was Not the First Bid: Warner Bros. Discovery Stock (NASDAQ:WBD) Gains as it Rejected Three Bids from Paramount So Far
- ‘Paramount Can Walk Away with Warner Bros.’ Say TD Cowen and Benchmark Analysts